MML Investors Services
IMVT icon

MML Investors Services’s Immunovant IMVT Stock Holding History

MML Investors Services’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Buy
+11,662
New +$355K ﹤0.01% 2544

Other funds holding IMVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MML Investors Services's IMVT Position: Q2 2026 in Review

MML Investors Services opened a new position in Immunovant (IMVT) in Q2 2026: 11,662 shares worth $449K. The stake represents ﹤0.01% of the portfolio and ranks #2544 among its holdings.

148 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • MML Investors Services held 11,662 shares of Immunovant worth $449K as of Q2 2026.
  • Immunovant was a new MML Investors Services position in Q2 2026.
  • Immunovant made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2544 holding.
  • 148 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.